|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/517 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 2355828 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09760383.1 |
| Date of filing the European patent application | 2009-11-13 | |
| (97) | Date of publication of the European application | 2011-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/064471 |
| Date | 2009-11-13 |
| (87) | Number | WO 2010/057048 |
| Date | 2010-05-20 |
| (30) | Number | Date | Country code |
| 155057 P | 2009-02-24 | US | |
| 231278 P | 2009-08-04 | US | |
| 180768 P | 2009-05-22 | US | |
| 114434 P | 2008-11-13 | US | |
| 245196 P | 2009-09-23 | US | |
| 142845 P | 2009-01-06 | US |
| (72) |
GALLATIN, Michael, W., US
ULRICH, Roger, G., US
GIESE, Neill, US
|
| (73) |
Gilead Calistoga LLC,
333 Lakeside Drive, Foster City. CA 94404,
US
|
| (54) | THERAPIES FOR HEMATOLOGIC MALIGNANCIES |
| THERAPIES FOR HEMATOLOGIC MALIGNANCIES |